|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.600 +0.020 (+0.775%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 811,630 | -9.755% | 1,706,556 | 1,317,711 | 1,637,659 | 978,111 |
| Cost of Sales | (87,018) | -2.114% | (167,263) | (128,382) | (241,893) | (184,284) |
| Gross Profit | 724,612 | -10.593% | 1,539,293 | 1,189,329 | 1,395,767 | 793,827 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,950) | 236.788% | (1,641) | (194) | 0 | 0 | |
| Profit / (Loss) before Taxation | 197,380 | -3.649% | 346,014 | 260,343 | 394,457 | 250,855 | |
| Taxation | (39,940) | 13.971% | (70,755) | (34,931) | (48,489) | (31,929) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 157,440 | -7.285% | 275,260 | 225,411 | 345,968 | 218,926 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (3,410) | -- | (1,131) | 2,594 | (636) | (6,159) |
| Depreciation & Amortisation | 26,480 | -15.169% | 59,876 | 41,913 | 32,971 | 27,599 |
| Directors' Emoluments | -- | -- | 8,331 | 8,594 | 9,616 | 8,478 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 27.740 | -6.662% | 48.270 | 39.270 | 60.000 | 37.880 |
| DPS (cts) | 6.000 | -- | 9.000 | 6.500 | 9.500 | 5.000 |
| Dividend Payout Ratio (%) | 21.629% | -- | 18.645% | 16.552% | 15.833% | 13.200% |
| Cash flow per share ($) | -- | -- | 0.595 | 0.667 | 0.710 | 0.518 |
| NBV per share ($) | 3.551 | -- | 3.389 | 3.029 | 3.013 | 2.472 |
| Remarks: | Real time quote last updated: 08/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 157,440,000 |
| %Change | -7.285% |
| EPS / (LPS) | HKD 0.277 |
| NBV Per Share ($) | HKD 3.551 |